LINC00844

Across TCGA pan-cancer cohorts, LINC00844 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated LINC00844 data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher LINC00844 RNA is associated with better overall survival. In most high-consensus cancer types, elevated LINC00844 expression acts as an unfavorable survival marker, although some lineages such as BRCA and KIRP show a favorable association.

BRCA, KIRP, and LGG are the cancer types where LINC00844 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Median	All	0.979	0.947	<.001	99	view →
KIRP	OS	Tertile	All	0.947	0.775	<.001	81	view →
LGG	DFS	Median	All	0.471	0.319	<.001	54	view →
LIHC	DFS	Quartile	II,III,IV	0.650	0.320	.001	54	view →
THYM	OS	Quartile	All	0.835	1.000	.002	42	view →
ACC	DFS	Median	All	0.872	0.604	.011	39	view →
KIRC	DFS	Quartile	IV	0.481	0.143	<.001	36	view →
CHOL	OS	Median	II,III,IV	0.323	0.710	.035	11	view →
BLCA	DFS	Tertile	IV	0.211	0.510	.010	9	view →
COAD	DFS	Tertile	IV	0.279	0.511	.032	9	view →
READ	OS	Tertile	IV	0.289	0.899	<.001	9	view →
THCA	DFS	Tertile	All	0.906	0.737	.010	7	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

LINC00844–BRCA (OS)

Open the BRCA breakdown →